Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 1931  |  »Ø¸´: 2
±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴

striving

Òø³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÖúCSCDÊÕÔØµÄÎÄÕÂһƪÎÄÕ¼ìË÷ºÅ

ÌâÄ¿£º»¯Ñ§ºÏ³ÉÔ­ÁÏÒ©ÆðʼÎïÁϹúÄÚÍâÏà¹ØÒªÇóµÄ±È½Ï
ÆÚ¿¯£ºÖйúÐÂÒ©ÔÓÖ¾
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sunshan4379

°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
striving: ½ð±Ò+5 2014-10-20 15:08:46
oven1986: LS-EPI+1, ¸ÐлӦÖú£¡ 2014-10-20 15:09:34
Comparison of domestic and foreign related requirements of starting materials for synthetic drug substances
»¯Ñ§ºÏ³ÉÔ­ÁÏÒ©ÆðʼÎïÁϹúÄÚÍâÏà¹ØÒªÇóµÄ±È½Ï
×÷Õß:Wang Hongliang; Chen Zhen
×÷Õß:ÍõºêÁÁ; ³ÂÕð
Chinese Journal New Drugs
ÖйúÐÂÒ©ÔÓÖ¾
¾í:23 ÆÚ:9 Ò³:998-1003
ÎÄÏ׺Å:1003-3734(2014)23:9<998:HXHCYL>2.0.TX;2-V
³ö°æÄê:2014
ÕªÒª
The selection and quality control of starting materials are an important part of drug substance development. In the past 20 years, this topic involves in the technical requirements for drug substance registration, and gets attention quite all time. As the publication of ICH Q11 guideline, agreement on general selection principles and quality control requirements of starting materials has been reached in ICH regions. In comparison, we are still lagging behind in the understanding of this topic. In this article, we reviewed FDA, EMA, ICH and domestic related requirements of starting materials for synthetic drug substances. Furthermore, we analyzed our existing problems focusing on the regulatory function, selection principles, and document submission requirements for starting materials. We want to provide a reference to amend the domestic related requirements for starting materials.
ÕªÒª:ÆðʼÎïÁϵÄÑ¡Ôñ¼°ÖÊÁ¿¿ØÖÆÊÇÔ­ÁÏÒ©¿ª·¢µÄÖØÒª×é³É²¿·Ö¡£½ü20ÄêÀ´,ÔÚÔ­ÁÏÒ©×¢²á¼¼ÊõÒªÇóÖÐ,ÕâÒ»»°ÌâÒ»Ö±¹ãÊܹØ×¢¡£Ëæ×ÅICH Q11Ö¸µ¼Ô­ÔòµÄ³ǫ̈,ICHµØÇø¶ÔÆðʼÎïÁÏÑ¡ÔñµÄ»ù±¾Ô­Ôò¼°ÖÊÁ¿¿ØÖÆÒªÇó´ï³É¹²Ê¶¡£Ïà±È½Ï¶øÑÔ,ÎÒ¹ú¶Ô´ËÎÊÌâµÄÈÏʶÉÐÏÔÖͺ󡣱¾ÎĶÔÃÀ¹ú¡¢Å·ÃË¡¢ICHÒÔ¼°¹úÄÚ¹ØÓÚ»¯Ñ§ºÏ³ÉÔ­ÁÏÒ©ÆðʼÎïÁϵÄÏà¹ØÒªÇó½øÐÐÁË×ÛÊö,²¢¶ÔÎÒ¹úÔÚÆðʼÎïÁϵļà¹Ü×÷Óá¢Ñ¡ÔñÔ­Ôò¡¢×ÊÁÏÌá½»ÒªÇóµÈ·½Ãæ´æÔÚµÄÎÊÌâ½øÐÐÁË·ÖÎö,Ϊ½øÒ»²½ÍêÉÆÎÒ¹úµÄÏà¹ØÒªÇóÌṩ²Î¿¼¡£
¹Ø¼ü´Ê
×÷Õ߹ؼü´Ê:drug substance; starting material; guideline; technical requirements
×÷Õ߹ؼü´Ê:Ô­ÁÏÒ©; ÆðʼÎïÁÏ; Ö¸µ¼Ô­Ôò; ¼¼ÊõÒªÇó
×÷ÕßÐÅÏ¢
µØÖ·: Wang Hongliang, National Engineering Research Center for Strategic Drugs, Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China.
Chen Zhen, Center for Drug Evaluation,China Food and Drug Administration, Beijing 100038, China.
µØÖ·: ÍõºêÁÁ, ¾üÊÂҽѧ¿ÆÑ§Ôº¶¾ÎïÒ©ÎïÑо¿Ëù, ¹ú¼ÒÓ¦¼±·À¿ØÒ©Î﹤³Ì¼¼ÊõÑо¿ÖÐÐÄ, ±±¾© 100850, Öйú.
³ÂÕð, ¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí×ܾÖÒ©Æ·ÉóÆÀÖÐÐÄ, ±±¾© 100038, Öйú.
µç×ÓÓʼþµØÖ·:whl.pharmacy@gmail.com, chenzh@cde.org.cn
µç×ÓÓʼþµØÖ·:whl.pharmacy@gmail.com, chenzh@cde.org.cn
Àà±ð / ·ÖÀà
Ñо¿·½Ïòharmacology & Pharmacy (ÓÉ Thomson Reuters Ìṩ)
ÎÄÏ×ÐÅÏ¢
ÎÄÏ×ÀàÐÍ:Article
ÓïÖÖ:Chinese
Èë²ØºÅ:CSCD:5139351
ISSN:1003-3734
ÆäËûÐÅÏ¢
Öйú¿ÆÑ§ÒýÎÄÊý¾Ý¿âÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 18
ÔÚÖйú¿ÆÑ§ÒýÎÄÊý¾Ý¿âÖеı»ÒýƵ´Î: 0
·Çµ­²´ÎÞÒÔÃ÷Ö¾£¬·ÇÄþ¾²ÎÞÒÔÖÂÔ¶
2Â¥2014-10-20 15:05:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sunshan4379

°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¼ìË÷ºÅ
Èë²ØºÅ:CSCD:5139351
·Çµ­²´ÎÞÒÔÃ÷Ö¾£¬·ÇÄþ¾²ÎÞÒÔÖÂÔ¶
3Â¥2014-10-20 15:08:48
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ striving µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 297¹¤¿Æ£¬Çóµ÷¼Á? +13 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-12 13/650 2026-04-13 14:12 by dingyanbo1
[¿¼ÑÐ] 085408¹âµçÐÅÏ¢¹¤³Ìר˶355Ò»Ö¾Ô¸³¤´º¹â»úËùµ÷¼Á +3 Íõymaa 2026-04-13 3/150 2026-04-13 11:01 by zhshch
[¿¼ÑÐ] 0854µ÷¼Á +10 ³¤¹­°Á 2026-04-11 11/550 2026-04-13 10:38 by wp06
[¿¼ÑÐ] 0854µ÷¼Á +10 ³¤¹­°Á 2026-04-12 12/600 2026-04-13 08:49 by Sammy2
[¿¼ÑÐ] Ò»Ö¾Ô¸0807 ÊýÒ»Ó¢Ò» 313 ÓÐûÓжþÂÖµ÷¼Á +12 emokidd 2026-04-08 13/650 2026-04-13 08:32 by lhj2009
[¿¼ÑÐ] µçÆø×¨Ë¶320Çóµ÷¼Á +6 СÂé×Ó111 2026-04-10 6/300 2026-04-12 10:54 by lemon6009
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũ΢ÉúÎ288·Ö£¬ÈýÄêʵÑé¾­Àú +11 ´úfish 2026-04-09 11/550 2026-04-12 10:21 by Hayaay
[¿¼ÑÐ] 269Çóµ÷¼Á +11 °¡°¡ÎÒÎÒ 2026-04-07 11/550 2026-04-11 16:45 by vgtyfty
[¿¼ÑÐ] 296Çóµ÷¼Á +6 Íô£¡£¿£¡ 2026-04-09 6/300 2026-04-11 11:25 by zhq0425
[¿¼ÑÐ] »¯Ñ§308·ÖÇóµ÷¼Á +22 ÄãºÃÃ÷ÌìÄãºÃ 2026-04-07 24/1200 2026-04-11 11:14 by ChemPharm
[¿¼ÑÐ] 297Çóµ÷¼Á +9 Kwgyz 2026-04-09 9/450 2026-04-11 10:09 by zhq0425
[¿¼ÑÐ] 302·ÖÇóµ÷¼Á +9 ·²ÓïÆíÔ¸ 2026-04-08 10/500 2026-04-10 23:26 by 314126402
[¿¼ÑÐ] 265Çóµ÷¼Á +12 ·ç˵ËýÔçÍüÁË 2026-04-10 13/650 2026-04-10 18:56 by chemisry
[¿¼ÑÐ] 282£¬µçÆø¹¤³Ìרҵ£¬Çóµ÷¼Á£¬²»Ìôרҵ +9 jggshjkkm 2026-04-10 9/450 2026-04-10 14:55 by ÄæË®³Ë·ç
[¿¼²©] ²©Ê¿×Ô¼ö +7 ¿É¿ÉСÅÖ 2026-04-08 7/350 2026-04-10 08:28 by kimhero
[¿¼ÑÐ] ¿¼Ñе÷¼Á-²ÄÁÏÀà-284 +28 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-08 28/1400 2026-04-09 20:08 by µ¹Êý321?
[ÂÛÎÄͶ¸å] ÇóÖúÎÄÏ×Ô­ÎÄ 10+3 18500821399 2026-04-08 3/150 2026-04-09 16:56 by ±±¾©À³ÒðÈóÉ«
[¿¼ÑÐ] »¯Ñ§¹¤³ÌÓë¼¼Êõרҵһ־Ը¹þ¹¤³Ì 291·ÖBÇø ¹ú¼Ò¼¶´ó´´¸ºÔðÈË ÓÐÒ»×÷ÂÛÎÄ +13 Emmy~ 2026-04-09 13/650 2026-04-09 14:47 by onlyÖÜ
[¿¼ÑÐ] 344Çóµ÷¼Á +11 κ×Óper 2026-04-07 11/550 2026-04-07 23:01 by JourneyLucky
[¿¼ÑÐ] »úеµ÷¼Á +3 zzzbcb 2026-04-07 3/150 2026-04-07 22:19 by hemengdong
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û